ClinicalTrials.gg
Not yet recruitingNCT07452900S&S WellnessUpdated Mar 10, 2026

Using Integrated Care and Wearable Technology to Evaluate Outcomes of the Shields & Stripes Program for Veterans and First Responders

An observational study in Holistic Care, Mental Health and Sleep, sponsored by Baylor University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-03-10.

Primary conditionStress Disorders, Post-TraumaticRegistry: Psychological Well-BeingReclassifiedWhy we changed it
Registry
Psychological Well-Being — the first condition term the registry derived for this study.
ClinicalTrials.gg
Stress Disorders, Post-Traumatic
Why
  1. Psychological Well-Being is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Stress Disorders, Post-Traumatic.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Baylor University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
80
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,664 studies in Stress Disorders, Post-Traumatic with a site in United States — 340 open to participants now, 403 under way, 18 of them phase 3. Stress Disorders, Post-Traumatic · United States.

Planned enrollment
102nd of 165
80 · median 107
Started
2026
with 96 others
Observational
166 of 1,664
24 open now
Primary completion
2026-12
later than 97 of 402 live
Registered
1,569th of 1,664
by date

Among the 1,664 studies in Stress Disorders, Post-Traumatic with a site in United States, this one is the 102nd largest by planned enrollment of the 165 observational ones that give a count, is one of 97 that started in 2026, is one of 166 observational ones, reaches primary completion later than 97 of the 402 other live ones, and was the 1,569th registered.

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

340 of the 1,664 studies in Stress Disorders, Post-Traumatic with a site in United States are open now. Recruiting first, the newest first:

335 more — sign in →

All 340 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,664 studies in Stress Disorders, Post-Traumatic with a site in United States, or all of them as a file.
02

Study summary

This study aims to evaluate outcomes from the Shields \& Stripes (S\&S) program - a 12-week, multidisciplinary wellness intervention designed for veterans and first responders. The S\&S program integrates occupational therapy (OT), mental health (MH), physical therapy (PT), and registered dietitian (RD) services to promote recovery, resilience, and performance in individuals who have experienced cumulative stress, trauma exposure, or occupational burnout.

This research will use a retrospective mixed-methods observational design to analyze data collected from previous S\&S participants who consent to research use of their de-identified information. No intervention or treatment changes will occur as part of this study.

Quantitative data will include biometric information (e.g., sleep, activity, and heart rate variability via Oura Ring), standardized self-report measures (GAD-7, PHQ-9, PCL-5, RAND-36, PSQI, ISI), satisfaction surveys, and laboratory nutrition panels. Qualitative data will include semi-structured interviews with consenting participants and S\&S providers following program completion.

The purpose of the study is to identify patterns of improvement in physical, psychological, and occupational functioning and to explore how integrated, team-based care supports holistic recovery. Findings may inform the development of future evidence-based wellness programs for military and first-responder populations.

Participation involves minimal risk, and all data will be de-identified before analysis.

Read the detailed description

Study Overview This retrospective mixed-methods observational study evaluates the effectiveness of the Shields \& Stripes (S\&S) program, a 12-week integrated wellness model that combines occupational therapy (OT), mental health (MH) services, physical therapy (PT), and registered dietitian (RD) support. The program serves veterans and first responders who experience cumulative physical, cognitive, and emotional stress related to their service.

The study will retrospectively analyze quantitative and qualitative data from S\&S cohorts between 2024-2026 to assess changes in health, functioning, and quality of life.

Objectives

Evaluate changes in physical, psychological, and occupational functioning following participation in S\&S.

Explore relationships between biometric indicators (e.g., heart-rate variability, sleep, activity) and self-reported well-being.

Examine trends in nutrition and metabolic markers across cohorts.

Analyze participant and provider perspectives through qualitative interviews to better understand mechanisms of change and perceived program value.

Design and Methods

Design: Convergent mixed-methods retrospective observational study.

Quantitative Data: Includes biometric data (sleep, HRV, activity), self-report scales (GAD-7, PHQ-9, PCL-5, RAND-36, PSQI, ISI), and laboratory measures (cholesterol, glucose regulation, vitamin D, testosterone, thyroid, inflammatory markers, etc.).

Qualitative Data: Semi-structured interviews with consenting participants and providers conducted post-program (via teleconference).

Participants: Veterans and first responders aged 18-70 who have completed the S\&S program and program providers who have worked within the S\&S program.

Recruitment: No direct external recruitment will occur for this study. All participants will be drawn from existing Shields \& Stripes program cohorts and affiliated program providers, which utilize processes separate from this research.

Data Handling: All data will be de-identified prior to analysis; stored securely on encrypted, access-restricted cloud servers.

Primary Outcomes

Change in self-reported anxiety (GAD-7)

Change in depressive symptoms (PHQ-9)

Change in PTSD symptoms (PCL-5)

Change in sleep (PSQI and ISI)

Change in quality of life (RAND-36)

Change in sleep quality and recovery metrics (Oura Ring data)

Secondary Outcomes

Changes in nutritional and metabolic lab results (e.g., cholesterol, glucose, vitamin D, thyroid function).

Qualitative themes related to perceived program benefit, barriers, and provider perspectives.

Duration and Setting Data will be collected retrospectively from cohorts between 2024-2026. The study will take place remotely with data stored and analyzed by the research team.

Risk and Safeguards The study is minimal risk. No interventions or procedures are performed beyond standard program participation. Risks are limited to potential discomfort during interviews and minimal risk of confidentiality breach, mitigated through HIPAA-compliant data handling.

Expected Impact Results will inform how multidisciplinary programs combining OT, MH, PT, and RD services improve functional, psychological, and physiological outcomes among high-stress occupational populations. The study aims to contribute to the evidence base for integrated, holistic wellness approaches for veterans and first responders.

03

Conditions studied

  • Holistic Care
  • Mental Health
  • Sleep
  • PTSD
  • Depression - Major Depressive Disorder
  • Anxiety
  • Resilience
  • Recovery
  • Occupation
  • Biometrics Measurement
  • Veteran
  • Quality of Life

Keywords

  • Shields & Stripes
  • Veterans
  • First Responders
  • Occupational Therapy
  • Mental Health
  • Physical Therapy
  • Registered Dietitian
  • Integrated Wellness
  • Biometric Data
  • Oura Ring
  • Sleep
  • Heart Rate Variability
  • PTSD
  • Anxiety
  • Depression
  • Quality of Life
  • Holistic Health
  • Multidisciplinary Rehabilitation
  • Functional Outcomes
04

In context

Stress Disorders, Post-Traumatic Reclassified

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

This study's planned enrollment of 80 is below the median of 150 across 371 observational studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Baylor University is the lead sponsor of 42 studies on the registry; 9 are open to participants now.

Compared within Stress Disorders, Post-Traumatic, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Psychological Well-Being. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of U.S. military veterans and first responders who have participated in the Shields \& Stripes 12-week multidisciplinary wellness program. The program integrates occupational therapy, mental health, physical therapy, and nutrition services. All data analyzed will be collected post-program completion, making the study primarily retrospective.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18-70 years
  • Current or former members of the U.S. Armed Forces or first responder professions (e.g., law enforcement, firefighting, EMS)
  • Participants who completed the Shields \& Stripes holistic wellness program
  • Providers who worked within the Shields and Stripes program.

Exclusion criteria

Exclusion Criteria:

-None

06

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Shields & Stripes Program Participants

    Participants include veterans and first responders who have completed the 12-week Shields \& Stripes holistic wellness program. The program integrates occupational therapy, mental health, physical therapy, and registered dietitian services to address physical, psychological, and occupational functioning. Data analyzed for this study include de-identified biometric, psychological, and laboratory outcomes collected as part of standard program procedures. Past and present program providers will also serve as participants to gain a better understanding of the program and its impact. No additional interventions are introduced for research purposes.

07

What researchers measure

Primary outcomes

  1. Change in Psychological Functioning Generalized Anxiety Disorder 7-item (GAD-7) scale

    To assess changes in anxiety symptoms before and after participation in the 12-week Shields \& Stripes program using validated self-report measures. Score range: 0 to 21 Higher scores indicate: Worse anxiety symptoms

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  2. Change in Psychological Functioning utilizing Patient Health Questionnaire-9 (PHQ-9)

    To assess changes in depression symptoms before and after participation in the 12-week Shields \& Stripes program using validated self-report measures. Score range: 0 to 27 Higher scores indicate: Worse depressive symptoms

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  3. Change in Psychological Functioning utilizing the Posttraumatic Stress Disorder Checklist (PCL-5)

    To assess changes in post-traumatic stress symptoms before and after participation in the 12-week Shields \& Stripes program using validated self-report measures. Score range: 0 to 80 Higher scores indicate: Worse PTSD symptoms

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

Secondary outcomes

  1. Change in Heart Rate Variability (HRV)

    Change in heart rate variability as measured by the Oura Ring wearable device. HRV will be reported as the nightly average root mean square of successive differences (RMSSD). Time Frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12) Unit of Measure: Milliseconds (ms) Directionality: Higher values indicate better autonomic nervous system balance and recovery.

    Time frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12)

  2. Change in Sleep Quality - Pittsburgh Sleep Quality Index (PSQI)

    Change in sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI), a validated 19-item self-report questionnaire assessing sleep quality and disturbances over the past month. Time Frame: Baseline (Week 0) to Post-Program (Week 12) Unit of Measure: Total PSQI global score (range: 0 to 21) Directionality: Higher scores indicate worse sleep quality.

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  3. Change in Health-Related Quality of Life - RAND 36-Item Health Survey (RAND-36)

    Change in health-related quality of life as measured by the RAND 36-Item Health Survey (RAND-36), a validated self-report questionnaire assessing eight domains including physical functioning, role limitations (physical and emotional), energy/fatigue, emotional well-being, social functioning, pain, and general health perceptions. Time Frame: Baseline (Week 0) to Post-Program (Week 12) Unit of Measure: RAND-36 subscale scores transformed to a 0-100 scale. Directionality: Higher scores indicate better health-related quality of life and functioning.

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  4. Change in Total Cholesterol

    Change in total cholesterol measured via standard laboratory testing. Unit of Measure: mg/dL Directionality: Lower values indicate improved lipid profile.

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  5. Qualitative Themes from Semi-Structured Interviews

    Participant and provider feedback will be collected using a semi-structured interview guide developed for this study. Thematic analysis will identify recurring themes related to participant satisfaction, perceived effectiveness, and experiences with integrated occupational therapy, mental health, physical therapy, and nutrition services. Time Frame: Post-Program (within 4 weeks of completion) Unit of Measure: Not applicable (qualitative thematic analysis)

    Time frame: Post-Program (within 4 weeks of completion)

  6. Change in Physical Function and Performance (PSFS)

    Change in self-reported physical function measured by the Patient-Specific Functional Scale (PSFS), reflecting improvements in self-identified functional goals and mobility. Time Frame: Baseline (Week 0) to Post-Program (Week 12) Unit of Measure: Mean PSFS total score (0-10 scale) Directionality: Higher scores indicate better functional performance

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  7. Change in Sleep Duration

    Change in total nightly sleep duration as measured by the Oura Ring wearable device. Time Frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12) Unit of Measure: Hours (or minutes - choose one and stay consistent) Directionality: Higher values indicate longer sleep duration

    Time frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12)

  8. Change in Sleep Efficiency

    Change in sleep efficiency as measured by the Oura Ring wearable device. Sleep efficiency is calculated as the percentage of time in bed spent asleep. Time Frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12) Unit of Measure: Percentage (%) Directionality: Higher values indicate better sleep quality.

    Time frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12)

  9. Change in Resting Heart Rate

    Change in resting heart rate as measured by the Oura Ring wearable device. Time Frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12) Unit of Measure: Beats per minute (bpm) Directionality: Lower values generally indicate better cardiovascular fitness and recovery.

    Time frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12)

  10. Change in Physical Activity Level

    Change in average daily activity level as measured by the Oura Ring wearable device. Unit of Measure: Oura Activity Score (0-100 scale) Directionality: Higher values indicate greater physical activity.

    Time frame: Pre-Program (T-4 weeks), Program Start (Week 0), and Post-Program (Week 12)

  11. Change in Insomnia Severity - Insomnia Severity Index (ISI)

    Change in insomnia symptom severity as measured by the Insomnia Severity Index (ISI), a validated 7-item self-report questionnaire assessing perceived insomnia severity. Time Frame: Baseline (Week 0) to Post-Program (Week 12) Unit of Measure: Total ISI score (range: 0 to 28) Directionality: Higher scores indicate more severe insomnia symptoms.

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  12. Change in HDL Cholesterol

    Change in high-density lipoprotein (HDL) cholesterol measured via standard laboratory testing. Unit of Measure: mg/dL Directionality: Higher values indicate improved lipid profile.

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  13. Change in LDL Cholesterol

    Change in low-density lipoprotein (LDL) cholesterol measured via standard laboratory testing. Unit of Measure: mg/dL Directionality: Lower values indicate improved lipid profile.

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  14. Change in Triglycerides

    Description: Change in triglyceride levels measured via standard laboratory testing. Unit of Measure: mg/dL Directionality: Lower values indicate improved lipid profile.

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  15. Change in Fasting Glucose

    Description: Change in fasting blood glucose measured via standard laboratory testing. Unit of Measure: mg/dL Directionality: Lower values indicate improved glycemic control.

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  16. Change in Hemoglobin A1c (HbA1c)

    Description: Change in hemoglobin A1c (HbA1c), a measure of average blood glucose over approximately three months, measured via standard laboratory testing. Unit of Measure: Percent (%) Directionality: Lower values indicate improved glycemic control.

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  17. Change in High-Sensitivity C-Reactive Protein (hs-CRP)

    Description: Change in high-sensitivity C-reactive protein (hs-CRP), a biomarker of systemic inflammation, measured via standard laboratory testing. Unit of Measure: mg/L Directionality: Lower values indicate reduced systemic inflammation.

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  18. Change in Vitamin D (25-hydroxyvitamin D)

    Description: Change in serum 25-hydroxyvitamin D levels measured via standard laboratory testing. Unit of Measure: ng/mL Directionality: Higher values indicate improvement toward normal vitamin D status.

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

  19. Change in Thyroid Stimulating Hormone (TSH)

    Description: Change in thyroid stimulating hormone (TSH) levels measured via standard laboratory testing. Unit of Measure: mIU/L Directionality: Movement toward the normal reference range indicates improved thyroid function.

    Time frame: Baseline (Week 0) to Post-Program (Week 12)

08

Study locations

1 site
09

References and documents

Individual participant data

Plan to share: No — This study involves retrospective analysis of de-identified data collected from participants in the Shields \& Stripes program. Individual participant data (IPD) will not be shared with other researchers outside the study team. Only aggregated, de-identified results will be reported in publications and presentations.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2026; primary completion for Dec 2026, 8 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2025
First posted
Mar 5, 2026
StartEst.
Apr 1, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Apr 30, 2027
Last update
Mar 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07452900
Lead sponsor
Baylor University
Responsible party
Kelli Cabrera (Lecturer and Principal Investigator, Department of Occupational Therapy, Baylor University, Baylor University) — Principal investigator
First posted
Mar 5, 2026
Start date
Apr 1, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Mar 10, 2026

Study contacts

Kelli Cabrera, OTD
Contact
kelli_Cabrera@baylor.edu
413-561-6105

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion